Invention Grant
- Patent Title: Cerebrospinal fluid shunt having long term anti-occlusion agent delivery
-
Application No.: US15829047Application Date: 2017-12-01
-
Publication No.: US10646700B2Publication Date: 2020-05-12
- Inventor: Paul V. Trescony , Edouard Koullick
- Applicant: Medtronic PS Medical, Inc.
- Applicant Address: US CA Goleta
- Assignee: MEDTRONICS PS MEDICAL, INC.
- Current Assignee: MEDTRONICS PS MEDICAL, INC.
- Current Assignee Address: US CA Goleta
- Agency: Patterson Thuente Pedersen, P.A.
- Main IPC: A61M25/00
- IPC: A61M25/00 ; A61M27/00 ; A61L31/16

Abstract:
The invention includes a shunt for at least partial implantation into a patient that includes an elongated conduit having at least one lumen therethrough, that includes a proximal end for receipt of bodily fluids for flow through the shunt and a distal end for discharge of the bodily fluids from the shunt, and a long term source of at least one occlusion resistant agent, wherein said at least a portion of the at least one occlusion resistant agent can permeate through at least a portion of the elongated conduit. The invention also includes kits and systems.
Public/Granted literature
- US20180154122A1 CEREBROSPINAL FLUID SHUNT HAVING LONG TERM ANTI-OCCLUSION AGENT DELIVERY Public/Granted day:2018-06-07
Information query